5-fluoro-2,2'-cyclocytidine has been researched along with thioguanine anhydrous in 1 studies
| Studies (5-fluoro-2,2'-cyclocytidine) | Trials (5-fluoro-2,2'-cyclocytidine) | Recent Studies (post-2010) (5-fluoro-2,2'-cyclocytidine) | Studies (thioguanine anhydrous) | Trials (thioguanine anhydrous) | Recent Studies (post-2010) (thioguanine anhydrous) |
|---|---|---|---|---|---|
| 5 | 1 | 0 | 2,706 | 295 | 389 |
| Protein | Taxonomy | 5-fluoro-2,2'-cyclocytidine (IC50) | thioguanine anhydrous (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.5333 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.601 | |
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 5.516 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlin, Z; Burchenal, JH; Clarkson, B; Comacho, E; Dowling, M; Drapkin, RL; Dufour, P; Gee, TS; Kempin, S; McKenzie, S; Mertelsmann, R; Oettgen, HF; Passe, S; Thaler, HT; To, L | 1 |
1 trial(s) available for 5-fluoro-2,2'-cyclocytidine and thioguanine anhydrous
| Article | Year |
|---|---|
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
Topics: Adolescent; Adult; Aged; Ancitabine; Antineoplastic Agents; Bacterial Vaccines; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Pseudomonas aeruginosa; Random Allocation; Thioguanine | 1981 |